They are the most talked-about pharmaceuticals of the last few years. GLP-1s are diabetes drugs that are exploding in ...

ABC News’ medical contributor Dr. Alok Patel explains the World Health Organization’s newest guidelines that say GLP-1 medications alone are not a solution for the global obesity epidemic.

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said ...

The World Health Organization is now recommending GLP-1 drugs for adults trying to manage obesity. Dr. Natalie Azar explains ...

The World Health Organization issued new guidelines recommending the use of GLP-1 drugs for adults with obesity and called for action on manufacturing and affordability.

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...

The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

New WHO guidance calls for a worldwide obesity treatment “ecosystem” to ensure that GLP-1 weight-loss drugs are used fairly ...

Explore GLP-1 receptor agonists with experts Judith Heij-Hadavi and Nicole Snow: molecular design, patient care, oral therapies, and analytical insights.

Its involvement often leads to distortions and perverse incentives.

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Discover why General Mills (GIS) is a strong buy for 2024, offering high dividends, defensive stability, and attractive value ...